Published

Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal: Journal of Drug Delivery Science and Technology
Date: 2024-01-05
Source: OpenAlex
DOI: 10.1016/j.jddst.2023.105305
PubMed: Unavailable

Authors

L. Richter Jozef Al-Gousous Gabriel Lima Barros de Araújo Neal M. Davies Raimar Löbenberg

Watch author

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin2024-01-05

Related papers

Psilocybin biosynthesis enhancement through gene source optimizationMetabolic Engineering · 2025-04-15 In vivo production of psilocybin in E. coliMetabolic Engineering · 2019-09-20 Genome-based optimization of psilocybin and N,N-dimethyltryptamine biosynthetic pathways in E. coli using CRISPR-associated transposasesMetabolic Engineering · 2026-06-13 Engineering artificial biosynthetic pathways for efficient microbial production of psilocybin and psilocinMetabolic Engineering · 2025-11-04 “Biosynthesis of psilocybin and its nonnatural derivatives by a promiscuous psilocybin synthesis pathway in Escherichia coli”Biotechnology and Bioengineering · 2023-06-19 Metabolic engineering of Saccharomyces cerevisiae for the de novo production of psilocybin and related tryptamine derivativesMetabolic Engineering · 2020-03-25 Psilocybin Production With Genetically Modified Aspergillus nidulans Under Pressurized ConditionsBiotechnology and Bioengineering · 2025-12-29 PSILOCYBIN STUDIES TURN A NEW LEAFChemical & Engineering News · 2006-07-16